Related Experiment Videos
NMR studies on three optical active drug molecules.
E Bednarek1, J C Dobrowolski, A P Mazurek
1Drug Institute, 30/34 Chełmska Str. 00-725 Warsaw, Poland.
Acta Poloniae Pharmaceutica
|May 24, 2001
Summary
Nuclear Magnetic Resonance (NMR) spectroscopy can distinguish enantiomers using chiral solvating agents. This study explored three agents for analyzing chiral drugs like Fluoxetine hydrochloride, Ibuprofen, and Zolmitriptan.
Area of Science:
- Analytical Chemistry
- Organic Chemistry
- Spectroscopy
Background:
- Nuclear Magnetic Resonance (NMR) spectroscopy is crucial for molecular structure elucidation.
- Distinguishing enantiomers, critical in pharmaceuticals, often requires chiral derivatizing or solvating agents.
- Optically active agents interact differently with enantiomers, enabling their differentiation via NMR.
Purpose of the Study:
- To conduct a preliminary NMR study on three chiral drugs: Fluoxetine hydrochloride, Ibuprofen, and Zolmitriptan.
- To evaluate the efficacy of three distinct chiral solvating agents in differentiating enantiomers of these drugs.
- To assess the potential of NMR spectroscopy with chiral solvating agents for enantiomeric analysis in drug development.
Main Methods:
- Utilized Nuclear Magnetic Resonance (NMR) spectroscopy.
- Employed three chiral solvating agents: R(-) 2,2,2-trifluoro-1-(9-anthryl)ethanol (I), (R)(+) 1,1'-bi-2-naphthol (II), and (S) tert-butyl-phenylphosphinothioic acid (III).
- Investigated the NMR spectral changes upon addition of chiral solvating agents to samples of Fluoxetine hydrochloride, Ibuprofen, and Zolmitriptan.
Main Results:
- Preliminary NMR data were obtained for the studied chiral drugs in the presence of the chiral solvating agents.
- Observed spectral differences indicate the potential of these agents to differentiate enantiomers.
- The study provides a foundation for further optimization of NMR methods for enantiomeric excess determination.
Conclusions:
- NMR spectroscopy, in conjunction with appropriate chiral solvating agents, shows promise for enantiomeric differentiation of chiral drugs.
- The selected agents (I, II, and III) demonstrated preliminary capability in interacting with and potentially distinguishing enantiomers of Fluoxetine hydrochloride, Ibuprofen, and Zolmitriptan.
- Further research is warranted to fully validate and optimize this approach for routine enantiomeric analysis in pharmaceutical quality control.